- Language: English
- 774 Pages
- Published: October 2012
- Region: Global
Santaris Pharma A/S
- Published: February 2013
- Region: Global
- 1 pages
- Sheila Greco Associates
Santaris Pharma AS is a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The Company`s proprietary Locked Nucleic Acid LNA drug platform, in combination with its highly specialized and targeted drug development capabilities, offers potential partners pre-screened drug candidates for commercial consideration across a multitude of disease states. The Company`s own research and development activities focus on infectious diseases and metabolic disorders while partnerships with major pharmaceutical companies include a range of therapeutic areas including cancer, rare genetic disorders and inflammatory diseases. Santaris Pharma AS, founded in 2003, is privately-held and headquartered in Denmark with operations in the US. The Company has strategic partnerships with Enzon Pharmaceuticals, GlaxoSmithKline, Wyeth Pharmaceuticals now part of Pfizer and Shire plc.
These individual Business Lists are 100% staff verified and details the company’s roster of key professionals and key decision makers.
- In addition to the executive contacts, this report contains:
- Global HQ Location
- US Address (Street, City, State & Zip)
- US HQ Phone Number & Company Website Address
- Most Recent
- Revenues Reported,
- Number of Employees and Industry.
These Business Lists do not include direct-dial phone numbers for all executives listed.
- This will provide the direct phone number.
- This report provides the HQ phone number and the accurate executive name and title.